
Codexis CDXS
€ 1.40
-1.8%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Codexis P/B 2011-2025 | CDXS
P/B Jährlich Codexis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.35 | 2.85 | 2.06 | 12.3 | 7.62 | 8.58 | 16.4 | 16.9 | 10 | 6.98 | 5.55 | 1.7 | 1.06 | 2.03 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.9 | 1.06 | 7.02 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.98 | 5.73 % | $ 826 M | ||
|
Aclaris Therapeutics
ACRS
|
0.979 | $ 3.36 | 3.38 % | $ 260 M | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Aptorum Group Limited
APM
|
0.347 | $ 1.28 | -1.54 % | $ 6.98 M | ||
|
Aptevo Therapeutics
APVO
|
0.187 | $ 1.06 | -6.19 % | $ 293 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
8.34 | $ 219.93 | -0.22 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.22 | -2.13 % | $ 7.75 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
BioVie
BIVI
|
0.128 | $ 1.39 | -4.14 % | $ 2.05 M | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 94.04 | -0.82 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.87 | 2.37 % | $ 1.25 B | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
1.38 | $ 9.55 | -0.16 % | $ 140 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 0.28 | -2.44 % | $ 609 M | ||
|
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | ||
|
Catalyst Biosciences
CBIO
|
0.428 | $ 13.96 | -0.91 % | $ 919 M | ||
|
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
17.1 | $ 548.13 | -2.86 % | $ 41.5 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.37 | 3.04 % | $ 14.9 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | $ 91.16 | 1.48 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 8.94 | -0.72 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.39 | -1.26 % | $ 737 M | ||
|
Biogen
BIIB
|
1.16 | $ 172.02 | -1.19 % | $ 25 B | ||
|
Abeona Therapeutics
ABEO
|
10.1 | $ 5.12 | -4.48 % | $ 109 M | ||
|
ADiTx Therapeutics
ADTX
|
0.00714 | $ 1.72 | -23.11 % | $ 22.7 K | ||
|
Cellectar Biosciences
CLRB
|
-3.23 | $ 3.34 | -7.73 % | $ 40.8 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
0.549 | - | - | - | ||
|
Фармсинтез
LIFE
|
1.97 | - | - | - |